Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

DHT, a testosterone byproduct, causes male pattern baldness.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

No cure for female pattern hair loss, but various effective treatments exist.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.